Article RETRACTED due to malpractice Methodological Approach to Addressing Joint Replacement Challenges in Osteopetrosis: A Clinical Review Perspective
DOI:
https://doi.org/10.47197/retos.v82.119200Keywords:
Osteoclasts, Osteopetrosis, Hip, Knee, Joint Replacement, Arthroplasty, Arthritis.Abstract
Osteopetrosis is considered a source of concern and a health problem because it is a rare disease that is difficult to detect and leads to many health risks. Osteopetrosis is a rare condition represented by a process disrupting normal bone formation and remodeling, which causes deformation of the teeth and skeleton, this deformity develops over time, causing an imbalance in the mineral balance. Also, osteopetrosis appears due to increased bone thickness and defective formation and disorganization, especially in areas of concentrated stress, such as the subtrochanteric areas, hip, knee, and femoral neck. The complication of osteopetrosis is degenerative osteoarthritis (OA) and directly affects hip or knee replacement operations in patients. The present review summarizes the most important previous and contemporary information and concepts and provides a detailed description of osteopetrosis, its causes, and risks that can be found in previous reviews and literature. In addition, the most important information and results reached in this literature regarding hip and knee joint replacement and its relationship to osteopetrosis. In our review, we emphasize the need to evaluate the results of recent studies related to osteopetrosis and its relationship to hip and knee joint replacements and how to detect and deal with this disease. In addition, it contributes to providing evidence-based information to help clinicians and researchers evaluate osteopetrosis and its impact on the hip and knee joints and increase their motivation to pay attention to this field.
References
1. Wu, C. C., Econs, M. J., DiMeglio, L. A., Insogna, K. L., Levine, M. A., Orchard, P. J., ... & Polgreen, L. E. (2017). Diagnosis and management of osteopetrosis: consensus guidelines from the osteopetrosis working group. The Journal of Clinical Endocrinology & Metabolism, 102(9), 3111-3123. https://doi.org/10.1210/jc.2017-01127
2. Strickland, J. P., & Berry, D. J. (2005). Total joint arthroplasty in patients with osteopetrosis: a report of 5 cases and review of the literature. The Journal of arthroplasty, 20(6), 815-820. https://doi.org/10.1016/j.arth.2004.11.015
3. Coudert, A. E., de Vernejoul, M. C., Muraca, M., & Del Fattore, A. (2015). Osteopetrosis and its relevance for the discovery of new functions associated with the skeleton. International journal of endocrinology, 2015. https://doi.org/10.1155/2015/372156
4. Vernejoul, M. C., & Benichou, O. (2001). Human osteopetrosis and other sclerosing disorders: recent genetic developments. Calcified Tissue International, 69(1), 1. https://doi.org/10.1007/s002230020046
5. Del Fattore, A., Teti, A., & Rucci, N. (2012). Bone cells and the mechanisms of bone remodelling. Frontiers in Bioscience-Elite, 4(6), 2302-2321.
6. Charles, J. F., & Aliprantis, A. O. (2014). Osteoclasts: more than ‘bone eaters’. Trends in molecular medicine, 20(8), 449-459. https://doi.org/10.1016%2Fj.molmed.2014.06.001
7. Sharma, S. S., Saravanan, C., Sathyabama, V., & Satish, C. (2013). Osteopetrosis of the mandible masquerading as tubercular osteomyelitis. Case Reports, 2013, bcr2012007487. https://doi.org/10.1136%2Fbcr-2012-007487
8. Cohen-Solal, M., Collet, C., Bizot, P., Pavis, C., & Funck-Brentano, T. (2023). Osteopetrosis: The patient point of view and medical challenges. Bone, 167, 116635. https://doi.org/10.1016/j.bone.2022.116635
9. Manzi, G., Romanò, D., Moneghini, L., & Romanò, C. L. (2012). Successful staged hip replacement in septic hip osteoarthritis in osteopetrosis: a case report. BMC Musculoskeletal Disorders, 13, 1-6. https://doi.org/10.1186/1471-2474-13-50
10. Lam, D. K., Sándor, G. K., Holmes, H. I., Carmichael, R. P., & Clokie, C. M. (2007). Marble bone disease: a review of osteopetrosis and its oral health implications for dentists. Journal of the Canadian Dental Association, 73(9), 839-844.
11. Siljander, M. P., Trousdale, R. T., Perry, K. I., Mabry, T. M., Berry, D. J., & Abdel, M. P. (2021). Total hip arthroplasty in patients with osteopetrosis. The Journal of Arthroplasty, 36(4), 1367-1372. https://doi.org/10.1016/j.arth.2020.10.018
12. Comulada, D. B., Rivera, L., Echegaray, G., Colón, R., Rodríguez-Santiago, S., & Otero, A. (2020). Bilateral posterior-stabilized total knee arthroplasty in a patient with osteopetrosis and literature review. Arthroplasty Today, 6(4), 866-871. https://doi.org/10.1016/j.artd.2020.09.016
13. Mayer, S. W., Hug, K. T., Hansen, B. J., & Bolognesi, M. P. (2012). Total knee arthroplasty in osteopetrosis using patient-specific instrumentation. The Journal of Arthroplasty, 27(8), 1580-e1. http://dx.doi.org/10.1016/j.arth.2011.12.007
14. Bollerslev, J., & Mosekilde, L. (1993). Autosomal dominant osteopetrosis. Clinical Orthopaedic Management of the Patient With Osteopetrosiss and Related Research (1976-2007), 294, 45-51.
15. Xie, L., Ding, F., Jiao, J., Kan, W., & Wang, J. (2015). Total Hip and Knee arthroplasty in a patient with osteopetrosis: a case report and review of the literature. BMC musculoskeletal disorders, 16, 1-5. https://doi.org/10.1186/s12891-015-0716-x
16. Jacome-Galarza, C. E., Percin, G. I., Muller, J. T., Mass, E., Lazarov, T., Eitler, J., ... & Geissmann, F. (2019). Developmental origin, functional maintenance and genetic rescue of osteoclasts. Nature, 568(7753), 541-545. https://doi.org/10.1038%2Fs41586-019-1105-7
17. Chen, L. R., Ko, N. Y., & Chen, K. H. (2019). Medical treatment for osteoporosis: from molecular to clinical opinions. International journal of molecular sciences, 20(9), 2213. https://doi.org/10.3390/ijms20092213
18. Ng, P. Y., Brigitte Patricia Ribet, A., & Pavlos, N. J. (2019). Membrane trafficking in osteoclasts and implications for osteoporosis. Biochemical Society Transactions, 47(2), 639-650. https://doi.org/10.1042/BST20180445
19. Bailey, J. R., & Tapscott, D. C. (2023). Continuing Education Activity.
20. Stark, Z., & Savarirayan, R. (2009). Osteopetrosis. Orphanet journal of rare diseases, 4, 1-12. https://doi.org/10.1186/1750-1172-4-5
21. Manolagas, S. C. (2000). Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocrine reviews, 21(2), 115-137.
22. Walker, D. G. (1973). Osteopetrosis cured by temporary parabiosis. Science, 180(4088), 875-875.
23. Kovanlikaya, A., Loro, M. L., & Gilsanz, V. (1997). Pathogenesis of osteosclerosis in autosomal dominant osteopetrosis. AJR. American journal of roentgenology, 168(4), 929-932.
24. Penna, S., Capo, V., Palagano, E., Sobacchi, C., & Villa, A. (2019). One disease, many genes: implications for the treatment of osteopetroses. Frontiers in Endocrinology, 10, 443083. https://doi.org/10.3389/fendo.2019.00085
25. Sobacchi, C., Schulz, A., Coxon, F. P., Villa, A., & Helfrich, M. H. (2013). Osteopetrosis: genetics, treatment and new insights into osteoclast function. Nature Reviews Endocrinology, 9(9), 522-536. https://doi.org/ 10.1038/nrendo.2013.137
26. Charles, J. F., & Aliprantis, A. O. (2014). Osteoclasts: more than ‘bone eaters’. Trends in molecular medicine, 20(8), 449-459. https://doi.org/10.1016%2Fj.molmed.2014.06.001
27. Guntur, A. R., & Rosen, C. J. (2012). Bone as an endocrine organ. Endocrine Practice, 18(5), 758-762. https://doi.org/10.4158/EP12141.RA.
28. Oury, F. (2012). A crosstalk between bone and gonads. Annals of the New York Academy of Sciences, 1260(1), 1-7. https://doi.org/10.1111/j.1749-6632.2011.06360.x
29. Lange, U., Teichmann, J., Schett, G., Neumann, E., & Müller-Ladner, U. (2013). Osteoimmunology: how inflammation influences bone metabolism. Deutsche Medizinische Wochenschrift (1946), 138(37), 1845-1849. https://doi.org/10.1055/s-0033-1349486
30. Blin-Wakkach, C., Rouleau, M., & Wakkach, A. (2014). Roles of osteoclasts in the control of medullary hematopoietic niches. Archives of biochemistry and biophysics, 561, 29-37. https://doi.org/10.1016/j.abb.2014.06.032
31. Schulz, A., & Kornak, U. (2015). CLCN7-related osteopetrosis. GeneReviews.
32. Papagrigorakis, E., Galanis, A., Vlachos, C., Vavourakis, M., Zachariou, D., Vlamis, J., & Pneumaticos, S. (2022). Periprosthetic fracture of total hip replacement in patients with osteopetrosis: A case presentation and review of literature. Journal of Frailty, Sarcopenia and Falls, 7(4), 251. https://doi.org/10.22540%2FJFSF-07-251
33. Waguespack, S. G., Hui, S. L., DiMeglio, L. A., & Econs, M. J. (2007). Autosomal dominant osteopetrosis: clinical severity and natural history of 94 subjects with a chloride channel 7 gene mutation. The Journal of Clinical Endocrinology & Metabolism, 92(3), 771-778. https://doi.org/10.1210/jc.2006-1986
34. Bollerslev, J., & Andersen, P. E. (1989). Fracture patterns in two types of autosomal-dominant osteopetrosis. Acta Orthopaedica Scandinavica, 60(1), 110-112. https://doi.org/10.3109/17453678909150106
35. Bollerslev, J., & Mosekilde, L. (1993). Autosomal dominant osteopetrosis. Clinical Orthopaedics and Related Research (1976-2007), 294, 45-51.
36. Alkhayal, Z., Shinwari, Z., Gaafar, A., & Alaiya, A. (2023). Carbonic anhydrase II activators in osteopetrosis treatment: A review. Current Issues in Molecular Biology, 45(2), 1373-1386. https://doi.org/10.3390/cimb45020089
37. Jiang, Y., Zhang, P., Zhang, X., Lv, L., & Zhou, Y. (2021). Advances in mesenchymal stem cell transplantation for the treatment of osteoporosis. Cell proliferation, 54(1), e12956. https://doi.org/10.1111/cpr.12956
38. Jimi, E., & Katagiri, T. (2022). Critical roles of NF-κB signaling molecules in bone metabolism revealed by genetic mutations in osteopetrosis. International journal of molecular sciences, 23(14), 7995. https://doi.org/10.3390/ijms23147995
39. Huybrechts, Y., & Van Hul, W. (2022). Osteopetrosis associated with PLEKHM1 and SNX10 genes, both involved in osteoclast vesicular trafficking. Bone, 164, 116520. https://doi.org/10.1016/J.BONE.2022.116520
40. Landa, J., Margolis, N., & Di Cesare, P. (2007). Orthopaedic management of the patient with osteopetrosis. JAAOS-Journal of the American Academy of Orthopaedic Surgeons, 15(11), 654-662.
41. Sobacchi, C., Schulz, A., Coxon, F. P., Villa, A., & Helfrich, M. H. (2013). Osteopetrosis: genetics, treatment and new insights into osteoclast function. Nature Reviews Endocrinology, 9(9), 522-536.
42. Roopashri, R. K., Gopakumar, R., & Subhas, B. G. (2008). Osteomyelitis in infantile osteopetrosis: a case report with review of literature. Journal of Indian Society of Pedodontics and Preventive Dentistry, 26(Supplement), S125-S128.
43. Tolar, J., Teitelbaum, S. L., & Orchard, P. J. (2004). Mechanisms of disease. Osteopetrosis. N Eng J Eng J Med, 351, 2839-2849.
44. CJ, J. (1971). Osteoarthritis associated with osteopetrosis treated by total hip replacement arthroplasty: report of a case. Clevel Clin, 38, 169-177.
45. Sivasankar, M., Arunkumar, S., Bakkiyaraj, V., Muruganandam, A., & Sathishkumar, S. (2016). A review on total hip replacement. International research journal in advanced engineering and technology, IRJAET, 2(2), 589-592.
46. Gold, M., Munjal, A., & Varacallo, M. (2017). Anatomy, bony pelvis and lower limb, hip joint.
47. Thudium, C. S., Nielsen, S. H., Sardar, S., Mobasheri, A., van Spil, W. E., Lories, R., ... & Karsdal, M. A. (2020). Bone phenotypes in rheumatology–there is more to bone than just bone. BMC Musculoskeletal Disorders, 21, 1-20. https://doi.org/10.1186/s12891-020-03804-2
48. Health Investigators. (2019). Total hip arthroplasty or hemiarthroplasty for hip fracture. New England Journal of Medicine, 381(23), 2199-2208. https://doi.org/10.1056/NEJMoa1906190
49. Ghalme, S. G., Mankar, A., & Bhalerao, Y. (2016). Biomaterials in hip joint replacement. Int. J. Mater. Sci. Eng, 4(2), 113-125. https://doi.org/10.17706/ijmse.2016.4.2.113-125
50. Girard, J., Vendittoli, P. A., Lavigne, M., & Roy, A. G. (2006). Resurfacing arthroplasty of the hip in osteopetrosis. The Journal of Bone & Joint Surgery British Volume, 88(6), 818-821. https://doi.org/10.1302/0301-620X.88B6
51. Cameron, H. U., & Dewar, F. P. (1977). Degenerative osteoarthritis associated with osteopetrosis. Clinical Orthopaedics and Related Research (1976-2007), 127, 148-149. https://doi.org/10.1097/00003086-197709000-00019
52. Gupton, M., Imonugo, O., & Terreberry, R. R. (2018). Anatomy, bony pelvis and lower limb, knee.
53. Chang, A., Breeland, G., Black, A. C., & Hubbard, J. B. (2023). Anatomy, Bony Pelvis and Lower Limb: Femur. In StatPearls [Internet]. StatPearls Publishing.
54. Hyland, S., Sinkler, M. A., & Varacallo, M. (2018). Anatomy, bony pelvis and lower limb, popliteal region.
55. Kim, S. E., & Han, H. S. (2024). Robotic arm-assisted total knee arthroplasty in a patient with osteopetrosis: a case report and review of literature. Orthopedic Reviews, 16. https://doi.org/10.52965/001c.94238
56. Hsu, H., & Siwiec, R. M. (2018). Knee arthroplasty.
57. Davies, P. S., Graham, S. M., Maqungo, S., & Harrison, W. J. (2019). Total joint replacement in sub-Saharan Africa: a systematic review. Tropical Doctor, 49(2), 120-128. https://doi.org/10.1177/0049475518822239
58. Adie, S., Harris, I., Chuan, A., Lewis, P., & Naylor, J. M. (2019). Selecting and optimising patients for total knee arthroplasty. Medical Journal of Australia, 210(3), 135-141.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Rimmi sen
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and ensure the magazine the right to be the first publication of the work as licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of authorship of the work and the initial publication in this magazine.
- Authors can establish separate additional agreements for non-exclusive distribution of the version of the work published in the journal (eg, to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Is allowed and authors are encouraged to disseminate their work electronically (eg, in institutional repositories or on their own website) prior to and during the submission process, as it can lead to productive exchanges, as well as to a subpoena more Early and more of published work (See The Effect of Open Access) (in English).
This journal provides immediate open access to its content (BOAI, http://legacy.earlham.edu/~peters/fos/boaifaq.htm#openaccess) on the principle that making research freely available to the public supports a greater global exchange of knowledge. The authors may download the papers from the journal website, or will be provided with the PDF version of the article via e-mail.
